Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
11,823,764
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
5,909,706
-
Shares change
-
+781,679
-
Total reported value, excl. options
-
$133,205,244
-
Value change
-
+$16,635,084
-
Number of buys
-
43
-
Number of sells
-
-11
-
Price
-
$22.54
Significant Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) as of Q2 2025
67 filings reported holding PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q2 2025.
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,909,706 shares
of 11,823,764 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (722,400 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (714,463 shares), BVF INC/IL (696,555 shares), Woodline Partners LP (445,615 shares), BlackRock, Inc. (445,052 shares), SAMSARA BIOCAPITAL, LLC (339,743 shares), MILLENNIUM MANAGEMENT LLC (314,989 shares), ADAMS STREET PARTNERS LLC (298,986 shares), Nantahala Capital Management, LLC (250,062 shares), and GEODE CAPITAL MANAGEMENT, LLC (173,986 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.